GB1415256A - Alpha-aminomethylbenzyl alcohol derivatives - Google Patents

Alpha-aminomethylbenzyl alcohol derivatives

Info

Publication number
GB1415256A
GB1415256A GB273373A GB273373A GB1415256A GB 1415256 A GB1415256 A GB 1415256A GB 273373 A GB273373 A GB 273373A GB 273373 A GB273373 A GB 273373A GB 1415256 A GB1415256 A GB 1415256A
Authority
GB
United Kingdom
Prior art keywords
group
benzyl
methyl
substituted
benzyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB273373A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27455937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB1415256(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP1312172A external-priority patent/JPS5653537B2/ja
Priority claimed from JP3941672A external-priority patent/JPS49237A/ja
Priority claimed from JP5101372A external-priority patent/JPS495934A/ja
Priority claimed from JP5292572A external-priority patent/JPS497239A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of GB1415256A publication Critical patent/GB1415256A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/74Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C215/76Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Abstract

1415256 α - Aminomethylbenzyl alcohols YAMANOUCHI PHARMACEUTICAL CO Ltd 18 Jan 1973 [5 Feb 1972 19 April 1972 23 May 1972] 2733/73 Heading C2C The invention comprises compounds of Formula I in which one of A and B represents a hydrogen atom or a hydroxyl group while the other represents a group of Formula Ia (wherein R<SP>1</SP> 1 which is different from R<SP>2</SP>, represents a hydrogen atom or an alkyl group and R<SP>2</SP> represents a hydrogen atom or a group COR<SP>4</SP> in which R<SP>4</SP> is H or an alkyl group which may have been substituted by a hydroxy, alkoxy or acylamino group), and R<SP>3</SP> represents an alkyl group other than a methyl group or a phenylalkyl group which may have been substituted by a hydroxyl group, an alkyl group, an alkoxy group or an acylamino group and pharmacologically acceptable additive salts thereof. The compounds of Formula I may be prepared by reduction of the corresponding substituted acetophenone and/or by hydrogenolysis of the corresponding benzyl compounds in which benzyl groups are attached to the phenolic oxygen or the amino group attached to R<SP>2</SP>. α-Bromoacetophenones in which the ring is substituted in the 4-position by OH, benzyloxy or NO 2 and in the 3-position by NO 2 , acetylamino or benzyloxyacetylamino groups are prepared by bromination of the corresponding acetophenone. α - (N,N - disubstituted amino)acetophenones substituted in the ring by a 4-benzyloxy group, a 3-group selected from NO 2 , acetylamino, benzyloxyacetylamino, NH 2 and having one N-benzyl group, the other substituent being selected from isopropyl, t-butyl, i-methyl-2- p-hydroxy phenyl ethyl, 1-methyl-2-p-acetylaminophenylethyl and 1-methyl-2-p-methoxyphenylethyl, and 4 - nitro - α - (N-benzyl - N - tertbutyl-amino)acetophenone are prepared by reaction of the correspondingly substituted α-bromo acetophenones with an appropriate amine and the keto groups are reduced with sodium borohydride to obtain the corresponding substituted benzyl alcohols. α - (N,N - disubstituted amino)acetophenones having a 3- or 4-nitro group in the ring are reduced to the corresponding amines by reaction with inon powder or by hydrogenation. The aromatic amino group thus prdouced is formylated by reaction with formic acid in acetic anhydride or with formic acid in the presence of dicyclohexylcarbodiimide. 4 - Benzyloxy - 3 - benzyloxyacetylamino acetophenone and 3-acetylamino-4-benzyloxy acetophenone are prepared from their respective 3-amino compounds by reaction with benzyloxyacetylchloride and acetic anhydride respectively. 4 - Benzyloxy - 3 - methylamino - α - (N- benzyl - N - t - butylamino - methyl)benzyl alcohol is prepared by reduction of the corresponding 3-formylamino compound with LiAlH 4 and is reacted with formic acid in acetic anhydride to obtain the corresponding N-formyl- N-methyl derivative. 3 - Amino - 4 - benzyloxy - α - [N - benzyl - N- (1 - methyl - 2 - p - hydroxy - phenylethyl)aminomethyl]benzyl alcohol is obtained by hydrolysis of the corresponding 3-formylamino compound and is reacted with acetic anhydride or benzyloxyacetylchloride to prepare the corresponding 3-acetylamino or 3-benzyloxyacetylamino compounds respectively. Pharmaceutical compositions having α-adrenergic activity for oral or parenteral or injection administration comprise a compound of Formula I together with a pharmaceutically acceptable diluent or medium.
GB273373A 1972-02-05 1973-01-18 Alpha-aminomethylbenzyl alcohol derivatives Expired GB1415256A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP1312172A JPS5653537B2 (en) 1972-02-05 1972-02-05
JP3941672A JPS49237A (en) 1972-04-19 1972-04-19
JP5101372A JPS495934A (en) 1972-05-23 1972-05-23
JP5292572A JPS497239A (en) 1972-05-27 1972-05-27

Publications (1)

Publication Number Publication Date
GB1415256A true GB1415256A (en) 1975-11-26

Family

ID=27455937

Family Applications (1)

Application Number Title Priority Date Filing Date
GB273373A Expired GB1415256A (en) 1972-02-05 1973-01-18 Alpha-aminomethylbenzyl alcohol derivatives

Country Status (3)

Country Link
DK (1) DK135578B (en)
FR (1) FR2173993B1 (en)
GB (1) GB1415256A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037740A2 (en) * 1980-04-07 1981-10-14 Yamanouchi Pharmaceutical Co., Ltd. Solid microdose drug preparation
WO2009032764A1 (en) 2007-08-28 2009-03-12 Sepracor Inc. Acetamide stereoisomer
EP2266590A2 (en) 2002-02-22 2010-12-29 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
US8173829B2 (en) 2007-08-28 2012-05-08 Sunovion Pharmaceuticals Inc. Carbamate stereoisomer

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE739678A (en) * 1969-10-01 1970-04-01 1 subst phenyl 2 amino ethanols useful as beta - adrenergic agents peripheral vasodilators and hypo-

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037740A2 (en) * 1980-04-07 1981-10-14 Yamanouchi Pharmaceutical Co., Ltd. Solid microdose drug preparation
EP0037740A3 (en) * 1980-04-07 1982-05-12 Yamanouchi Pharmaceutical Co. Ltd. Solid microdose drug preparation
EP2266590A2 (en) 2002-02-22 2010-12-29 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
WO2009032764A1 (en) 2007-08-28 2009-03-12 Sepracor Inc. Acetamide stereoisomer
US8173829B2 (en) 2007-08-28 2012-05-08 Sunovion Pharmaceuticals Inc. Carbamate stereoisomer

Also Published As

Publication number Publication date
DK135578B (en) 1977-05-23
FR2173993A1 (en) 1973-10-12
DK135578C (en) 1977-10-31
FR2173993B1 (en) 1976-12-03

Similar Documents

Publication Publication Date Title
AU6294298A (en) Matrix metalloproteinase inhibitors
GB1351430A (en) Substituted 1,2,4-triazole derivatives
FI981437A (en) Imides useful as PDE III, PDE IV and TNF inhibitors
GB1463575A (en) Vinca alkaloid derivatives
GB1392674A (en) Dopamine derivatives
GB1415256A (en) Alpha-aminomethylbenzyl alcohol derivatives
ES346521A1 (en) N-(sulfonylcarbamoyl)-bornano-(3&#39;,2&#39;:4,5)-oxazolidin-3-ones
GB1367598A (en) Derivatives of delta 1-pyrroline their method of preparation and their applications
Bianchi et al. The Anticonvulsant Properties of 2-Methyl-3-p-Bromophenyl-3 H-4-Quinazolone Hydrochloride (BDH 1880) and Some Related Compounds
ES419936A1 (en) 1-hydroxy-1-((4&#39;-hydroxy-3&#39;aminosulfonamido)-phenyl)-2-amino-ethanes and salts
GB1379781A (en) Furylmethyl morphinane derivatives and pharmaceutical compositions containing them
GB1364505A (en) F phenylalanine amide derivatives
GB1373548A (en) Anti-hypertensive 6-substituted 3-hydrazino-pyridazines and their preparation
GB1288647A (en)
GB1394962A (en) 1-ethylimidazoles their production and their medicinal use
GB1140188A (en) Pyrroline derivatives
ES381534A2 (en) A procedure for the preparation of new derivatives of 1-phenyl-2-aminoetanol. (Machine-translation by Google Translate, not legally binding)
GB1453417A (en) Nitroimidazoles
GB1504709A (en) N-substituted quinolinone-2-carboxyl. acid der
GB919491A (en) Pharmaceutical compositions
GB1304599A (en)
GB1474907A (en) Pyrolidine derivatives
GB1256593A (en)
GB1167262A (en) 0-Sulphonyl-5,5-Disubstituted-Hydantoins and process for preparation thereof
GB1512763A (en) 3-nitropyrazole-4-acrylic acid derivatives

Legal Events

Date Code Title Description
PS Patent sealed
CTFF Certificate filed

Free format text: SPC/GB93/009, 930115

PE20 Patent expired after termination of 20 years

Effective date: 19930116

CTFR Application for certificate rejected

Free format text: SPC/GB93/009, 930908

CTFR Application for certificate rejected

Free format text: SPC/GB93/009, 19930908